{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T23:24:01Z","timestamp":1695425041411},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/mph.0b013e318266ba72","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T21:30:11Z","timestamp":1371159011000},"page":"e298-e300","source":"Crossref","is-referenced-by-count":5,"title":["Successful Response to Cidofovir of Adenovirus Hepatitis During Chemotherapy in a Child With Hepatoblastoma"],"prefix":"10.1097","volume":"34","author":[{"given":"M. Elena","family":"Mateos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"L\u00f3pez-Laso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan L.","family":"P\u00e9rez-Navero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jos\u00e9","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jos\u00e9","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-33-20210227","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10096-004-1165-x","article-title":"Treatment of adenovirus infections in the immunocompromised host.","volume":"23","author":"Ljungman","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R3-33-20210227","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.mph.0000153958.95486.6f","article-title":"Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia.","volume":"27","author":"Hough","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R4-33-20210227","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.","volume":"361","author":"Perilongo","year":"2009","journal-title":"N Engl J Med"},{"key":"R5-33-20210227","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.tp.0000209195.95115.8e","article-title":"Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.","volume":"81","author":"Yusuf","year":"2006","journal-title":"Transplantation"},{"key":"R6-33-20210227","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pbc.21120","article-title":"Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia.","volume":"50","author":"Steiner","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R7-33-20210227","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/15513819309048238","article-title":"Pathology of the liver in severe combined immunodeficiency and DiGeorge syndrome.","volume":"13","author":"Washington","year":"1993","journal-title":"Pediatr Pathol"},{"key":"R8-33-20210227","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/08880010290057390","article-title":"A rare case of adenoviral fulminant hepatic necrosis after chemotherapy.","volume":"19","author":"Kaur","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"R9-33-20210227","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1399-3046.2008.01014.x","article-title":"Adenovirus infection and treatment with cidofovir in children after liver transplantation.","volume":"13","author":"Engelmann","year":"2009","journal-title":"Pediatr Transplant"},{"key":"R10-33-20210227","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00006454-200011000-00016","article-title":"Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient.","volume":"19","author":"Arav-Boger","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R11-33-20210227","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/514978","article-title":"Disseminated adenovirus disease in immunocompromised and immunocompetent children.","volume":"27","author":"Munoz","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R12-33-20210227","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"R13-33-20210227","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbmt.2006.08.040","article-title":"Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.","volume":"13","author":"Neofytos","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R14-33-20210227","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/MPH.0b013e3181b7873e","article-title":"A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection.","volume":"31","author":"Williams","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R15-33-20210227","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-3046.2007.00851.x","article-title":"High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy.","volume":"12","author":"Anderson","year":"2008","journal-title":"Pediatr Transplant"},{"key":"R16-33-20210227","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1128\/AAC.41.8.1846","article-title":"Fanconi syndrome associated with cidofovir therapy.","volume":"41","author":"Vittecoq","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-33-20210227","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1399-3062.2009.00391.x","article-title":"Safety and tolerability of cidofovir in high-risk pediatric patients.","volume":"11","author":"Bhadri","year":"2009","journal-title":"Transpl Infect Dis"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e318266ba72","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:13:06Z","timestamp":1620965586000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201210000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e318266ba72","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}